Get the Stockscreener App
302.09
2.59%
7.64
After Hours:
301.81
-0.28
-0.09%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $302.09, with a volume of 3.80M.
It is up +2.59% in the last 24 hours and down -13.00% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$294.45
Open:
$290.46
24h Volume:
3.80M
Relative Volume:
1.74
Market Cap:
$115.81B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
34.99
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
+3.34%
1M Performance:
-13.00%
6M Performance:
-19.10%
1Y Performance:
-22.05%
1-Day Range:
$290.00
$303.73
1-Week Range:
$281.00
$303.73
52-Week Range:
$281.00
$404.14
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
302.09 | 112.88B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
83.83 | 146.92B | 45.13B | 6.28B | 7.38B | 3.5895 |
MDT
Medtronic Plc
|
76.21 | 98.63B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.06 | 80.41B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
81.39 | 45.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker Corp Stock (SYK) Moved Up by 3.02% on May 13: Drivers Behind the Movement - TradingKey
Stryker Corp stock (US8636671013): Shares rise 3.5% on vascular M&A momentum - AD HOC NEWS
Stryker Corp stock (US8636671013): HR chief's recent share sales - AD HOC NEWS
Argus cuts Stryker stock price target on cyberattack impact - Investing.com India
Stryker Corp (SYK) Shares Surge 3.1% -- What GF Score of 92 Tells Investors - GuruFocus
[Form 4] STRYKER CORP Insider Trading Activity - Stock Titan
Stryker Corp. Hits New 52-Week Low at USD 284.98 - Markets Mojo
Stryker Corp Shs Sponsored Canadian Depository Receipt Hedged Reg S Revenue Breakdown – TSX:SYK - TradingView
Argus cuts Stryker stock price target on cyberattack impact By Investing.com - Investing.com Canada
Stryker Corp. stock outperforms competitors despite losses on the day - MarketWatch
[144] STRYKER CORP SEC Filing - Stock Titan
Stryker (NYSE:SYK) Hits New 1-Year LowWhat's Next? - MarketBeat
SYK SEC FilingsStryker Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Ernest Wong's Top Picks: Stryker, Ind. Gross Yield & Waste Connections - BNN Bloomberg
Stryker (NYSE: SYK) grows Q1 2026 sales as cyber incident weighs on margins - Stock Titan
We Like The Quality Of Stryker's (NYSE:SYK) Earnings - 富途牛牛
Stryker Corp stock (US8636671013): ABN AMRO sells 78,873 shares - AD HOC NEWS
STRYKER FCF Margin %: 6.89% — 54% Below Median - GuruFocus
Stryker Corp at Citigroup Inc Unplugged Medtech and Life Sciences Access Day Transcript - GuruFocus
Stryker Corp (TSX:SYK) Stock Earnings Transcripts - GuruFocus
Stryker Corp (TSX:SYK) Competitors 2026 - GuruFocus
Stryker Corp (TSX:SYK) Stock Price & 30 Year Financial Data - GuruFocus
Stryker Corp (TSX:SYK)Valuation Measures & Financial Statistics - GuruFocus
Stryker Corp (TSX:SYK) Valuation - GuruFocus
Stryker Corp (TSX:SYK) Dividend - GuruFocus
Stryker Corp Stock Intrinsic Values - GuruFocus
Stryker Corp Stock Operating Data - GuruFocus
Who's Buying or Selling Stryker Corp (TSX:SYK) Stock Today? - GuruFocus
Stryker Corp Stock Historical Valuations - GuruFocus
Stryker Corp (TSX:SYK) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Stryker Corp (TSX:SYK) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Stryker Corp Stock Warning Signs | TSX:SYK - GuruFocus
Stryker Corp (TSX:SYK) Stock Price, Trades & News - GuruFocus
Stryker's (NYSE:SYK) Earnings Offer More Than Meets The Eye - Yahoo! Finance Canada
Stryker Corp. stock (US8636671013): Q1 earnings miss and dividend hike in focus - AD HOC NEWS
Stryker Corp | 4: Statement of changes in beneficial ownership of securities-Director Suri Rajeev - Moomoo
Stryker (NYSE: SYK) director granted 762 RSUs in equity award - Stock Titan
Stryker (SYK) director receives 762 RSUs, lifting holdings to 5,205 shares - Stock Titan
Stryker (NYSE: SYK) director receives 762 restricted stock units award - Stock Titan
Director at Stryker (NYSE: SYK) receives 762 RSUs vesting 2027 - Stock Titan
Stryker Corp | 4: Statement of changes in beneficial ownership of securities-Director McCoy Sherilyn S - Moomoo
Stryker Corp (NYSE: SYK) director awarded 762 deferred RSUs - Stock Titan
Stryker Corp | 4: Statement of changes in beneficial ownership of securities-Director Caforio Giovanni - Moomoo
Stryker Corp. stock underperforms Friday when compared to competitors - MarketWatch
Stryker (NYSE: SYK) director granted 762 RSUs vesting in 2027 - Stock Titan
Stryker (NYSE: SYK) awards 677 RSUs to VP Montagnino - Stock Titan
Stryker (NYSE: SYK) officer Debra King receives 1,016 RSUs in equity award - Stock Titan
Stryker shareholders re-elect board and approve executive pay at annual meeting - Investing.com UK
Stryker (NYSE: SYK) reports detailed 2026 shareholder vote results - Stock Titan
Computer Vision in Healthcare Market Report 2026: Revenue Expected to Surpass $33.4 Billion by 2036 - GlobeNewswire Inc.
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):